In this research paper, Fang. W, et. al explored the ground-breaking potential of a single droplet microsensor in identifying ultra-short circulating tumor EGFR mutations, opening up new avenues for multiplex EFIRM liquid biopsy.
In layman’s terms, a single droplet of patient liquid tissue could be used to quickly identify rare DNA mutations indicative of tumor growth in the lungs, when combined with an electrical field-induced release and measurement (EFIRM). This research used a BioDot Omnia combined with a Rainmaker dispenser to place 50pL probe droplets and control droplets.
Join us the BioDot family with the cutting-edge technology that has revolutionized the practice of precision medicine. This innovative technique can revolutionize how we detect lung cancer, offering priceless information for individualized treatment plans.